US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist
  • 0.820
  • +0.008+0.96%
Close Aug 6 16:00 ET
  • 0.812
  • -0.008-0.94%
Post 20:01 ET
22.39MMarket Cap-1066P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunoPrecise Antibodies Earnings Date

Currency: CAD

Period

Q4 FY2024 Earnings

Jul 29, 2024

Revenue(YoY)

6.46M

+14.91%
EPS(YoY)

-0.70

-233.33%
Analyst Rating

No Data

ImmunoPrecise Antibodies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 7.400M--
--2025/Q1-- / 6.800M--
Jul 29, 20242024/Q46.459M / 6.530M--
Mar 14, 20242024/Q36.221M / 6.068M--
Dec 14, 20232024/Q26.150M / 5.853M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 7.400M--
--2025/Q1-- / 6.800M--
Jul 29, 20242024/Q46.459M / 6.530M--
Mar 14, 20242024/Q36.221M / 6.068M--
Dec 14, 20232024/Q26.150M / 5.853M--

Unlock Free Earnings Estimates

ImmunoPrecise Antibodies Earnings Reports

  • ImmunoPrecise Antibodies | 20-F: Registration statement / Annual report / Transition report

    Jul 29 08:44 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 29 08:39 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 24 06:05 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 15 08:34 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg